The FDA approved a supplemental new drug application for roflumilast topical foam 0.3% for the treatment of plaque psoriasis ...

According to the American Academy of Dermatology, it’s common in those with oily skin or hair, acne, or psoriasis ... they spread quickly as children share combs, brushes, and hats.

The 0.3% foam formulation of roflumilast was previously approved for the treatment of seborrheic dermatitis in adults and ...

She also mentioned how it connects to her past treatments for psoriasis ... If you could do some hair, you’ll never be broke,” Knowles said. “I told my kids that. My mama told me that.

and plaque psoriasis from head to toe. It lasted for seven months. For those seven months, I didn’t feel like myself. The pain was constant. I couldn’t be present for my kids the way I wanted ...